Iguratimod

Iguratimod is used in the treatment of Ulcerative colitis, Crohn’s disease, systemic lupus erythematosus, Wilson's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and type 2 diabetes mellitus.

Iguratimod is a disease-modifying anti-rheumatic drug (DMARD). It works by improving abnormal immunological response and suppressing the production of substances that cause inflammation (redness and swelling) in rheumatoid arthritis.

Diarrhea, Nausea, Rash, Abdominal pain, Vomiting, Stomatitis (Inflammation of the mouth), Photosensitivity, Decreased appetite, Itching, Hives, Nasopharyngitis (inflammation of the throat and nasal passages), Increased aspartate aminotransferase, Increased alanine aminotransferase, Aplastic anemia